Characteristics at baseline, at week 24, and at last follow-up for responders (n = 12)
| Characteristics . | Baseline, median (range) . | Week 24, median (range) . | P* . | Last follow-up, median (range) . | P* . |
|---|---|---|---|---|---|
| Symptom score | 16 (7-38) | 1 (0-6) | .003 | 0.5 (0-6) | .002 |
| IL-6, pg/mL | 28.6 (7.4-865) | 10.0 (2-23.5) | .012 | 3.7 (2-25.1) | .002 |
| Hemoglobin, g/L | 98 (76-133) | 125.5 (93-150) | .093 | 132 (93-177) | .013 |
| CRP, mg/L | 41.6 (0.2-185.6) | 12.4 (0.8-54.8) | .028 | 3.2 (0.7-53.0) | .005 |
| ESR, mm/h | 90 (6-115) | 31 (5-125) | .042 | 16 (1-125) | .013 |
| Albumin, g/L | 32 (26-43) | 37 (36.7-56) | .018 | 39.5 (36-56) | .007 |
| IgG, g/L | 21.7 (14.4-43.8) | 12.4 (7.3-20.3) | .012 | 14.5 (7.9-24.6) | .002 |
| Characteristics . | Baseline, median (range) . | Week 24, median (range) . | P* . | Last follow-up, median (range) . | P* . |
|---|---|---|---|---|---|
| Symptom score | 16 (7-38) | 1 (0-6) | .003 | 0.5 (0-6) | .002 |
| IL-6, pg/mL | 28.6 (7.4-865) | 10.0 (2-23.5) | .012 | 3.7 (2-25.1) | .002 |
| Hemoglobin, g/L | 98 (76-133) | 125.5 (93-150) | .093 | 132 (93-177) | .013 |
| CRP, mg/L | 41.6 (0.2-185.6) | 12.4 (0.8-54.8) | .028 | 3.2 (0.7-53.0) | .005 |
| ESR, mm/h | 90 (6-115) | 31 (5-125) | .042 | 16 (1-125) | .013 |
| Albumin, g/L | 32 (26-43) | 37 (36.7-56) | .018 | 39.5 (36-56) | .007 |
| IgG, g/L | 21.7 (14.4-43.8) | 12.4 (7.3-20.3) | .012 | 14.5 (7.9-24.6) | .002 |
Compared with baseline.